Monodora myristica is one of the plants used extensively in folkloric medicine across West Africa.
INTRODUCTION
Monodora myristica is a tropical tree of the Annonacea family of flowering plants widely distributed in sub-Saharan Africa 1,2 and some parts of Central and South America. 3, 4 In Nigeria, the plant is variously referred as Iwor (Itsekiri), Gujiya dan miya (Hausa), Ikposa (Benin), Ehuru (Igbo) and arigbo or eyi naghose (Yoruba), Ehinawosin (Ikale), Uyengben (Edo) and Fausse noix de muscade (French). 5 M. myristica has both economic and medicinal benefits. 6 Its stimulant, antiemetic, aperient, stomachic and tonic properties of the seed are well known 7 and the high mineral and essential oil constituents also provide nutritional benefits. 8 The seeds are rich in flavonoids, terpene, resins, anthraquinones, tannins, cyanogenic glycosides, alkaloids, arocine, lactose, saponins and steroids. 8 Some fifty-three phenolic compounds from the chloroform extract in addition to a few oils from the apolar solvent extract such as myrcene, α-pinene, limonene and α-phellandrene have been characterized. 9, 10 More so, several of the activities of the M. myristica seed have been attributed to these phytochemicals. [11] [12] [13] Although previous works have reported several biological activities of these extracts, information on the exact phytochemical(s), especially the oily-rich constituents, responsible for the bioactivities have obviously not been exhaustively described. For instance, only about ten phytochemicals were characterized by Adewole and co-workers, 10 this might represent a few percentage of the bulk constituents considering the high levels of myristicin (42.60%), caffeic acid (23.39%), elemicin (3.82%) and eugenol (1.02%) 14 and 5.9% colourless essential oil 12 contents previously reported. The present work, therefore, aimed to evaluate the crude extracts and solvent fractions with a view of understanding the distribution of the phytoconstituents across solvents of different polarities. In addition, the GC-MS fingerprint of the seed oil is characterized to further expand the library of phytochemicals identified from M. myristica seed.
MATERIALS AND METHODS

Chemicals.
All chemicals used for the study were of analytical grade and are described in the relevant sections. Unless otherwise stated, the chemicals and reagents were of appropriate grades from Sigma-Aldrich, Darmstadt, Germany and were used as supplied. Extraction of M. myristica seed oil. Exactly 900 g quantity of the powdered M. myristica seed (in portions of 9 x 100 g) was weighed and extracted exhaustively for 12 hrs in a Soxhlet extraction apparatus, with heater (Merck Chemicals GmbH, Darmstadt, Germany) using 4.5 L petroleum ether at the regulated temperature of 40 -60 o C. The solvent of the combined extracts was evaporated in vacuo at 40ºC using rotary vacuum evaporator (Rotavapor R-210, BÜCHI, Flawil, Switzerland) to a dry weight of 22.7%. The oil was stored at 4 o C prior to use and the defatted mass was preserved for further solvent extraction.
Extraction of M. myristica seed.
Further extraction of the dried mass was carried out by cold maceration. A quantity of exactly 600 g of the defatted mass of M. myristica seed was weighed and macerated into 1.5 L of 95% v/v methanol for a period of 24 hrs. The extraction was performed with four successive portions of fresh solvents and the combined extracts were completely evaporated invacuo with a rotary vacuum evaporator at 40°C to dry weight of 7.4%. The obtained extract was evaluated for phytochemical studies.
Fractionation of the extract from the mass of M. myristica. The obtained extract (44 g) was dissolved in 10% v/v aqueous methanol and partitioned successively in equal volumes of the following solvents in the order of n-hexane, dichloromethane, ethyl acetate and n-butanol. The respective solvent fractions of the extract were concentrated to dryness in vacuo at 40ºC and stored appropriately.
Phytochemical investigation. The crude methanol extract, solvent fractions and the extracted oils were tested for the phytochemical constituents such as flavonoids, tannins, cardiac glycosides, triterpenoids, steroids and saponins. These evaluations were done according to the methods described by Sofowora et al. and the methods of Trease and Evans. 15 
RESULTS
Phytochemical constituents of the oil, extract from mass and the fractions from M. myristica seed. The result in Table 1 shows the relative phytochemical composition of the oil, extract from mass and fractions from M. myristica seed. The oily extract was rich in sterols and triterpenoids. The triterpenoid composition of the oil was in same proportion with n-hexane and dichloromethane extracts. Similarly, sterols and triterpenoids in crude marc extract and ethyl acetate fractions were moderate. Expectedly, there was trace amount of cardiac glycosides, flavonoids, tannin and saponin in the oily crude extract and n-hexane solvent fraction of the marc extract.
Result of GC-MS analysis.
By the critical evaluation and spectrum comparison of the GC-MS spectra of the oil extract, the following compounds in Table 2 were unambiguously identified. 
DISCUSSION
M. myristica seed is a rich source of pharmaceutical and nutritional oil. Its application in formulation science has been reported and the appreciably high content (22.7 %) obtained in this study compares well with those reported in the previous similar studies. 1, 8 The phytochemical analysis of the extracted oil revealed the presence of medicinally important sterols and triterpenoids in high quantities. In particular, steroids-containing plant extract are important in the reduction of risk of coronary heart and neurodegenerative diseases in preand post-menopausal women. 4 The phytochemical constituents of the fractions showed polarity guided distribution of the phytochemicals in the respective solvents. Sterol and triterpenoids were abundant in n-hexane fraction; sterol, triterpenoids and trace of flavonoids in dichloromethane; sterol, triterpenoids, flavonoids, and much more polar constituents, cardiac glycosides, tannin and saponin in ethylacetate and sterol, triterpenoids, flavonoids, tannin and saponin predominantly in n-butanol fraction compare well with previous findings. 16 Armed with this information on the phytochemical constituents of defatted M. myristica seeds, a prospective research will be to subject these fractions to several biological assays which will enable the eventual isolation and characterization of the constituent(s) responsible for each observed activity. This is currently on-going.
The GC-MS analysis revealed the presence of about twenty (25) chemically related compounds, some of which have never been reported as constituents of M. myristica. Some of these compounds identified through the gas chromatography-mass spectrometry are known to have many important biological and formulation functions; α-limonene, for instance, is used to promote weight loss, prevent and treat cancer as well treat bronchitis. 17 In foods, beverages, and chewing gum, limonene is used as a flavoring agent. In addition, in pharmaceuticals, limonene is added to help medicinal ointments and creams penetrate the skin. 18 Germacrenes are typically produced in a number of plant species for their antimicrobial and insecticidal properties. 19 Cis oleic acid and oleic acid (in triglyceride form) is included in the normal human diet as a part of animal fats and vegetable oils. Oleic acid as its sodium salt is a major component of soap as an emulsifying agent. It is also used as an emollient. 20 Small amounts of oleic acid are used as excipient in pharmaceuticals, and it is used as an emulsifying or solubilizing agent in aerosol products. 20 As earlier reported by Adewole et al. 10 the GC-MS analysis further revealed presence of many other important compounds; n-hexadecanoic acid, pentadecanoic acid, n-octadecanoic acid, eicosanoic acid, hexeicosanoic acid, docosanoic acid and 9, 15octadecadienoate. The presence of this class of fatty acids further gives credence to the nutritional values of M. myristica seeds and possibly its potential ability to modulate the inflammatory pathways.
